You are here

Article Text

Article menu
Download PDFPDF
Conference report
Meeting report of the British Society for Gastroenterology Meeting, March 2003
  1. J I W Jones1,
  2. S I Khakoo2
  1. 1Division of Gastroenterology, University Hospital, Nottingham NG7 2UH, UK
  2. 2Division of Infection, Inflammation, and Repair, Southampton General Hospital, Southampton, UK
  1. Correspondence to:
    Dr S I Khakoo, MRC Clinician Scientist, Division of Infection, Inflammation, and Repair, Mailpoint 811, Level D South Block, Southampton General Hospital, Tremona Rd, Southampton, Hants SO16 6YD, UK;
    sik{at}soton.ac.uk

https://doi.org/10.1136/gut.52.9.1383

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The 2003 meeting of the British Society for Gastroenterology (BSG) was held at the ICC Birmingham. The range of subjects covered reflected the diversity of the speciality, and high quality clinical papers were in abundance. This contrasted with an interesting survey showing an apparent decline in the number of publications achieved by SpRs at the time of appointment to consultant grade from a median of 19 in 1993 to only five in 2001.1 Our ability to collect large amounts of clinical data are ever improving and current clinical practice came under scrutiny from a number of national and regional surveys. The BSG-blue card surveillance scheme was used to survey mortality from inflammatory bowel disease.2 This suggested that these diseases account for about 1% of all gastrointestinal deaths, and highlighted surgery and sepsis as key factors. The BSG also acted as a conduit for data collection for a national assessment of hepatitis C care in the UK.3 The survey demonstrated regional variation in both healthcare providers and treatment practice, and estimated that only about 5–10% of hepatitis C virus infected individuals are in secondary care. The theme …

    View Full Text